Multiple Myeloma

Preferred Label : Multiple Myeloma;

NCIt synonyms : Plasma Cell Myeloma/Multiple Myeloma; Multiple Myeloma/Plasma Cell Myeloma;

NCIt related terms : myeloma; MYELOMA, PLASMA CELL, MALIGNANT; Kahler disease; Myeloma, NOS; Plasma Cell Myeloma; myelomatosis;

NCIt definition : A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia. Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001);

Alternative definition : CDISC: A malignant neoplasm of the bone marrow composed of plasma cells.; NCI-GLOSS: A type of cancer that begins in plasma cells (white blood cells that produce antibodies).;

Neoplastic status : Malignant;

ICD-O code : 9732/3;

Codes from synonyms : CDR0000411384; CDR0000411383; CDR0000411381; 10028566; CDR0000045793; CDR0000045795;

Details

Origin ID

C3242;

UMLS CUI

C0026764;

Automatic exact mappings (from CISMeF team)
- Multiple myeloma [ACR pathology]
- Multiple myeloma [ACR pathology]
- Multiple myeloma [ACR pathology]
- Multiple myeloma [ACR pathology]
- Multiple myeloma [ACR pathology]
- Myeloma [ACR pathology]
- Myeloma [ACR pathology]
- Myeloma [ACR pathology]
- Myeloma [ACR pathology]
- Myeloma [ACR pathology]
- Myeloma [ACR pathology]
- Myeloma [ACR pathology]
- Myelomatosis [MedDRA LLT]
- Plasma cell myeloma [ICD-9 code]
- Plasma cell myelomas [MedDRA High Level Term]
- indolent plasma cell myeloma [DO Concept]
- malignant neoplasm blood other [ICPC-2 Rubric]
- myeloid neoplasm [DO Concept]
Currated CISMeF NLP mapping
- MULTIPLE MYELOMA [WHO-ART Included Term]
- Multiple myeloma [ICD-10 Sub-category]
- Multiple myeloma [ICD-10 Sub-category (who)]
- Multiple myeloma [HPO term]
- Multiple myeloma [ICD-O code]
- Multiple myeloma [ORDO Disease]
- Multiple myeloma [MedDRA LLT]
- Multiple myeloma [HRDO Sign]
- Multiple myeloma, no International Classification of Diseases for Oncology subtype (morphologic abnormality) [SNOMED CT concept]
- Myeloma [PASCAL descriptor]
- Myeloma [DRC RCE]
- Myeloma [TUV Concept]
- Myeloma [TUV Term]
- Myeloma [MedDRA LLT]
- Myeloma, multiple [OMIM Phenotype]
- Plasma cell myeloma [ICD-11 Extension code]
- Plasma cell myeloma [ICD-11 Subcategory]
- Plasma cell myeloma [MedDRA Preferred Term]
- multiple myeloma [DO Concept]
- multiple myeloma [Disease (Nov.)]
- multiple myeloma [MedlinePlus Topic]
- multiple myeloma [MeSH Descriptor]
- multiple myeloma [MeSH concept]
- multiple myeloma [SNOMED Notion]
- multiple myeloma [Radlex concept]
- myeloma [Blood Transfusion thesaurus concept]
DO Cross reference
- multiple myeloma [DO Concept]
Disease excludes abnormal cell
- Neoplastic T-Lymphocyte and Neoplastic Natural Killer Cell [NCIt concept]
Disease excludes normal cell origin
- Myeloid Cell [NCIt concept]
- Precursor B-Lymphoblast [NCIt concept]
False automatic mappings
- Multiple myeloma (disorder) [SNOMED CT concept]
Has associated anatomic sites
- Hematopoietic System [NCIt concept]
- Hematopoietic and Lymphatic System [NCIt concept]
Semantic type(s)
- Neoplastic Process [UMLS semantic type]
UMLS correspondences (same concept)
- MULTIPLE MYELOMA [WHO-ART Included Term]
- MYELOMATOSIS MULTIPLE [WHO-ART Preferred Term]
- Multiple myeloma [ICD-9 code]
- Multiple myeloma [ORDO Disease]
- Multiple myeloma [MedDRA LLT]
- Multiple myeloma [ICD-O code]
- Multiple myeloma [ICD-10 Sub-category]
- Multiple myeloma [HPO term]
- Multiple myeloma [HRDO Sign]
- Multiple myeloma [ICD-10 Sub-category (who)]
- Multiple myeloma (disorder) [SNOMED CT concept]
- Multiple myeloma, no International Classification of Diseases for Oncology subtype (morphologic abnormality) [SNOMED CT concept]
- Myeloma [MedDRA LLT]
- Myeloma [DRC RCE]
- Myeloma [TUV Concept]
- Myeloma [TUV Term]
- Myeloma [PASCAL descriptor]
- Myeloma, multiple [OMIM Phenotype]
- Myelomatosis [MedDRA LLT]
- Myelomatosis multiple [MedDRA LLT]
- Peripheral plasma cell myeloma [MedDRA LLT]
- Plasma cell myeloma [MedDRA Preferred Term]
- Plasma cell myeloma [ICD-11 Subcategory]
- Plasma cell myeloma (morphologic abnormality) [SNOMED CT concept]
- Plasma cell myelomas [MedDRA High Level Term]
- multiple myeloma [Radlex concept]
- multiple myeloma [DO Concept]
- multiple myeloma [Disease (Nov.)]
- multiple myeloma [MeSH concept]
- multiple myeloma [MedlinePlus Topic]
- multiple myeloma [MeSH Descriptor]
- multiple myeloma [SNOMED Notion]
associated_with_malfunction_of_gene_product
- Interleukin-6 [NCIt concept]
concept_is_in_subset
- CDISC SEND Terminology [NCIt concept]
- CDISC SEND Tumor Findings Results Terminology [NCIt concept]
- CPTAC Causes of Death Codelist [NCIt concept]
- CPTAC Codelists Terminology [NCIt concept]
- CPTAC Medical Conditions Codelist [NCIt concept]
- CPTAC Neoplasms Codelist [NCIt concept]
- CPTAC Terminology [NCIt concept]
- CTRP Disease Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- CTS-API Disease Main Type Terminology [NCIt concept]
- Cellosaurus Disease Terminology [NCIt concept]
- Cellosaurus Terminology [NCIt concept]
- Clinical Data Interchange Standards Consortium Terminology [NCIt concept]
- Clinical Trials Search-Application Programming Interface Disease Category Terminology [NCIt concept]
- GDC Terminology [NCIt concept]
- GDC Value Terminology [NCIt concept]
- Mapped ICDO3.1 Morphology PT Terminology [NCIt concept]
- Mapped ICDO3.1 Morphology Terminology [NCIt concept]
- Mapped ICDO3.1 Terminology [NCIt concept]
- Mapped ICDO3.2 Morphology PT Terminology [NCIt concept]
- Mapped ICDO3.2 Morphology Terminology [NCIt concept]
- Mapped ICDO3.2 Terminology [NCIt concept]
- NCI CTEP SDC Myeloma Sub-Category Terminology [NCIt concept]
- NCI CTEP Simplified Disease Classification Terminology [NCIt concept]
- NCIt Neoplasm Core Terminology [NCIt concept]
disease_excludes_finding
- Benign Cellular Infiltrate [NCIt concept]
- Localized Lesion [NCIt concept]
disease_has_abnormal_cell
- Abnormal Lymphocyte [NCIt concept]
- Malignant Cell [NCIt concept]
- Neoplastic B-Lymphocyte [NCIt concept]
- Neoplastic Cell [NCIt concept]
- Neoplastic Hematopoietic and Lymphoid Cell [NCIt concept]
- Neoplastic Lymphocyte [NCIt concept]
- Neoplastic Plasma Cell [NCIt concept]
disease_has_accepted_treatment_with_regimen
- BLD Regimen [NCIt concept]
- Bendamustine/Bortezomib/Dexamethasone Regimen [NCIt concept]
- Bendamustine/Carfilzomib/Dexamethasone Regimen [NCIt concept]
- Bortezomib/Daratumumab and Hyaluronidase/Dexamethasone Regimen [NCIt concept]
- Bortezomib/Dexamethasone/Panobinostat Regimen [NCIt concept]
- Bortezomib/Liposomal Doxorubicin Regimen [NCIt concept]
- CRd Regimen [NCIt concept]
- CVAD Regimen [NCIt concept]
- Carfilzomib/Dexamethasone Regimen [NCIt concept]
- Carfilzomib/Panobinostat Regimen [NCIt concept]
- DT-PACE Regimen [NCIt concept]
- Dara-KRd Regimen [NCIt concept]
- Dara-Rd Regimen [NCIt concept]
- Dara-Vd Regimen [NCIt concept]
- Daratumumab and Hyaluronidase/Dexamethasone/Lenalidomide Regimen [NCIt concept]
- Daratumumab/Hyaluronidase Regimen [NCIt concept]
- Dexamethasone/Ixazomib Regimen [NCIt concept]
- Dexamethasone/Lenalidomide Regimen [NCIt concept]
- Dexamethasone/Liposomal Doxorubicin/Vincristine Regimen [NCIt concept]
- Dexamethasone/Pomalidomide Regimen [NCIt concept]
- Elo-Rd Regimen [NCIt concept]
- Elo-Vd Regimen [NCIt concept]
- IRd Regimen [NCIt concept]
- Icd Regimen [NCIt concept]
- Isa-Kd Regimen [NCIt concept]
- KPD Regimen [NCIt concept]
- KRd Regimen [NCIt concept]
- Low-dose Dexamethasone/Lenalidomide Regimen [NCIt concept]
- MPT Regimen [NCIt concept]
- Melphalan/Prednisone Regimen [NCIt concept]
- PCD Regimen [NCIt concept]
- PVD Regimen [NCIt concept]
- TD Regimen [NCIt concept]
- VAD Regimen [NCIt concept]
- VBMCP Regimen [NCIt concept]
- VD Regimen [NCIt concept]
- VMCP Alternating with VBAP Regimen [NCIt concept]
- VMP Regimen [NCIt concept]
- VTD-PACE Regimen [NCIt concept]
- XPd Regimen [NCIt concept]
disease_has_associated_disease
- Plasma Cell Leukemia [NCIt concept]
- Plasma Cell Myeloma-Induced Bone Disease [NCIt concept]
- Recurrent Plasma Cell Leukemia [NCIt concept]
- Secondary Plasma Cell Leukemia [NCIt concept]
disease_has_associated_gene
- IL6 Gene [NCIt concept]
- IL6 wt Allele [NCIt concept]
- MIR106B Gene [NCIt concept]
- MIR106B wt Allele [NCIt concept]
- MIR181A1 Gene [NCIt concept]
- MIR181A1 wt Allele [NCIt concept]
- MIR181A2 Gene [NCIt concept]
- MIR181A2 wt Allele [NCIt concept]
- MIR181B1 Gene [NCIt concept]
- MIR181B1 wt Allele [NCIt concept]
- MIR181B2 Gene [NCIt concept]
- MIR181B2 wt Allele [NCIt concept]
- MIR194-1 Gene [NCIt concept]
- MIR194-1 wt Allele [NCIt concept]
- MIR19A Gene [NCIt concept]
- MIR19A wt Allele [NCIt concept]
- MIR19B1 Gene [NCIt concept]
- MIR19B1 wt Allele [NCIt concept]
- MIR215 Gene [NCIt concept]
- MIR215 wt Allele [NCIt concept]
- MIR25 Gene [NCIt concept]
- MIR25 wt Allele [NCIt concept]
- MIR32 Gene [NCIt concept]
- MIR32 wt Allele [NCIt concept]
- MIR93 Gene [NCIt concept]
- MIR93 wt Allele [NCIt concept]
- TACC3 Gene [NCIt concept]
- TACC3 wt Allele [NCIt concept]
disease_has_finding
- Aberrant Clonal Plasma Cell Population [NCIt concept]
- Malignant Cellular Infiltrate [NCIt concept]
- Neoplastic Plasma Cells Present in Bone Marrow [NCIt concept]
disease_has_molecular_abnormality
- Clonal Immunoglobulin Gene Rearrangement [NCIt concept]
disease_has_normal_cell_origin
- B-Lymphocyte [NCIt concept]
- Bone Marrow-Homing Plasma Cell [NCIt concept]
- Hematopoietic and Lymphoid Cell [NCIt concept]
- Lymphocyte [NCIt concept]
- Mature B-Lymphocyte [NCIt concept]
- Plasma Cell [NCIt concept]
disease_has_normal_tissue_origin
- Hematopoietic and Lymphoid Tissue [NCIt concept]
- Lymphoid Tissue [NCIt concept]
disease_has_primary_anatomic_site
- Hematopoietic and Lymphatic System [NCIt concept]
- Lymphatic System [NCIt concept]
disease_may_have_cytogenetic_abnormality
- t(11;14)(q13;q32) [NCIt concept]
may_be_associated_disease_of_disease
- AH Amyloidosis [NCIt concept]
- AHL Amyloidosis [NCIt concept]
- AL Amyloidosis [NCIt concept]
- Chronic Neutrophilic Leukemia [NCIt concept]
- Familial Primary Localized Cutaneous Amyloidosis-1 [NCIt concept]
- Heavy Chain Deposition Disease [NCIt concept]
- Light Chain Deposition Disease [NCIt concept]
- Light and Heavy Chain Deposition Disease [NCIt concept]
- Monoclonal Immunoglobulin Deposition Disease [NCIt concept]
- Primary Amyloidosis [NCIt concept]
- Primary Cutaneous Amyloidosis [NCIt concept]
- Primary Systemic Amyloidosis [NCIt concept]
- Recurrent AL Amyloidosis [NCIt concept]
- Recurrent Primary Amyloidosis [NCIt concept]
- Refractory AL Amyloidosis [NCIt concept]
- Refractory Primary Amyloidosis [NCIt concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients